Remi Chauveau Notes
Former Neuralink president Max Hodak is pivoting his biotech startup Science Corporation toward organ preservation, aiming to extend the viability of human organs for transplantation and longevity breakthroughs.
Technology 🚀

Max Hodak ex-Neuralink executive Is Getting Into Organ Preservation

17 December 2025
@drdavideagleman

Could we add another input/output channel to the brain? Join me to learn about new ways of interfacing with the brain in this week's Inner Cosmos with BCI pioneer Max Hodak. "What’s the future of connecting our tech to our brains?" #brain #BCI

♬ original sound - David Eagleman

🧠🎶 Basslines of Preservation

Phlegmatic DogsNext Level thrives on pushing boundaries in sound, layering grit and rhythm to reimagine what bass music can be—and that same spirit of escalation resonates with Max Hodak’s leap from brain‑tech at Neuralink to organ preservation. Just as the track declares a sonic “next level,” Hodak’s new venture seeks a biological next level: extending the life of human organs through innovation. Both are about transformation—taking what exists, remixing it with bold energy, and creating futures that pulse with possibility.

🎶 🧠♻️⚙️🌍🐇✨🚀🧩🦾🌀🔬💻⚡🤖📡 🔊 Next Level - Phlegmatic Dogs



Max Hodak, former president of Neuralink, is now steering his biotech startup Science Corporation toward organ preservation.

His new division aims to extend the viability of human organs, reshaping transplantation and life‑support technologies.

🧠 From Brain Interfaces to Organs

Science Corporation, founded in 2021 by Hodak, first focused on neural interfaces and vision‑restoring implants. Now, the company is pivoting to organ preservation, applying its expertise in biotechnology to a new frontier of longevity.

⚙️ Rethinking Perfusion Systems

Current organ perfusion machines, like ECMO, are bulky, expensive, and limited in duration. Hodak’s team is developing a compact, portable system that can sustain organs far longer, aiming to make preservation more accessible and affordable.

🐇 Early Breakthroughs

Science has already kept rabbit kidneys alive outside the body for up to 48 hours. The company hopes to extend this viability to a month by early 2026, a leap that could revolutionize transplant logistics.

🌍 Ethical and Global Impact

The inspiration for this project came from a tragic case of a young patient awaiting a lung transplant. Hodak envisions organ preservation as part of a broader longevity toolkit, reducing ethical dilemmas and expanding access worldwide.

✨ Future Vision

Looking ahead, Science Corporation plans to integrate sensors and automated controls into its perfusion systems. Hodak’s ultimate goal is to make organ preservation as routine as checking luggage, transforming healthcare and extending human life.

#BioInnovation 🧠 #OrganPreservation ⚙️ #LongevityScience 🌍 #FutureMedicine ✨ #LifeExtended 🐇

Organs Memory

Next Level Living Archives
Science Corporation isn’t just building machines to keep organs alive—it’s quietly developing a “digital twin” system that records the biological state of each preserved organ in real time. This means every kidney, lung, or heart placed in their perfusion device could carry a unique data profile: oxygen levels, nutrient flow, cellular stress markers. Over time, these profiles could form a massive dataset of “organ biographies,” allowing AI models to predict how long an individual organ will remain viable and even suggest personalized preservation tweaks. In other words, Hodak’s vision isn’t only about extending physical survival—it’s about creating a new layer of organ intelligence, where every transplant carries a story written in data.

Trending Now

Latest Post